Sam Wilson, CPA, is currently the Director, Corporate Controller at LENZ Therapeutics since 2025. They previously held the position of Director of Accounting at Dexcom from 2021 to 2025 and served as Director of Accounting at NuVasive from 2017 to 2018. Prior roles include Assurance Senior at Ernst & Young and Audit Senior/Staff at White, Nelson & Co. LLP. Sam earned a BS in Accounting from Southern Nazarene University in 2003.
This person is not in any teams
This person is not in any offices